Genpact (NYSE:G – Get Free Report) updated its first quarter 2026 earnings guidance on Thursday. The company provided EPS guidance of 0.920-0.930 for the period, compared to the consensus EPS estimate of 0.870. The company issued revenue guidance of $1.3 billion-$1.3 billion, compared to the consensus revenue estimate of $1.3 billion. Genpact also updated its FY 2026 guidance to 4.010-4.010 EPS.
Genpact Trading Up 3.5%
G stock traded up $1.31 during midday trading on Friday, reaching $39.01. The company’s stock had a trading volume of 1,204,318 shares, compared to its average volume of 1,725,192. Genpact has a 1 year low of $37.49 and a 1 year high of $56.76. The firm has a market capitalization of $6.73 billion, a price-to-earnings ratio of 12.58, a PEG ratio of 1.14 and a beta of 0.74. The stock has a fifty day simple moving average of $45.99 and a two-hundred day simple moving average of $43.79. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.51 and a current ratio of 1.51.
Genpact (NYSE:G – Get Free Report) last posted its quarterly earnings results on Thursday, February 5th. The business services provider reported $0.97 EPS for the quarter, topping analysts’ consensus estimates of $0.93 by $0.04. The firm had revenue of $1.32 billion for the quarter, compared to analysts’ expectations of $1.31 billion. Genpact had a net margin of 11.01% and a return on equity of 22.55%. The business’s revenue for the quarter was up 5.6% on a year-over-year basis. During the same period in the prior year, the business posted $0.91 earnings per share. Genpact has set its FY 2026 guidance at 4.010-4.010 EPS and its Q1 2026 guidance at 0.920-0.930 EPS. On average, equities research analysts predict that Genpact will post 3.21 EPS for the current year.
Genpact Increases Dividend
Wall Street Analyst Weigh In
A number of analysts recently issued reports on G shares. Needham & Company LLC lowered their price target on Genpact from $53.00 to $50.00 and set a “buy” rating for the company in a report on Friday. Weiss Ratings reiterated a “hold (c+)” rating on shares of Genpact in a report on Friday, December 26th. Wall Street Zen raised Genpact from a “hold” rating to a “buy” rating in a research report on Saturday, January 10th. Susquehanna set a $42.00 price objective on Genpact in a report on Friday. Finally, Citigroup raised shares of Genpact to a “hold” rating in a research note on Thursday, October 23rd. Two analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $49.13.
Check Out Our Latest Report on Genpact
Insider Buying and Selling at Genpact
In other Genpact news, Director Tamara Franklin sold 2,750 shares of the business’s stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $45.65, for a total value of $125,537.50. Following the completion of the transaction, the director directly owned 22,236 shares in the company, valued at approximately $1,015,073.40. The trade was a 11.01% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, SVP Sameer Dewan sold 26,531 shares of the stock in a transaction dated Tuesday, November 11th. The shares were sold at an average price of $44.70, for a total transaction of $1,185,935.70. Following the sale, the senior vice president directly owned 62,617 shares of the company’s stock, valued at approximately $2,798,979.90. The trade was a 29.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 60,385 shares of company stock worth $2,762,475 over the last quarter. Insiders own 3.07% of the company’s stock.
Key Stories Impacting Genpact
Here are the key news stories impacting Genpact this week:
- Positive Sentiment: Company raised outlook: Genpact issued Q1 2026 EPS guidance of $0.920–$0.930 (above consensus ~$0.87) and FY 2026 EPS guidance of $4.01 (above consensus ~$3.77), signaling stronger forward earnings power and driving optimism. Genpact Reports Fourth Quarter and Full Year 2025 Results
- Positive Sentiment: Dividend raised and declared: Genpact increased its quarterly dividend by 10% to $0.1875 (annualized yield ~2.0%) and set record/ex-dividend dates, which supports income-focused investor demand. Genpact Reports Fourth Quarter and Full Year 2025 Results
- Positive Sentiment: FY results show growth and margin progress: 2025 net revenues rose ~6.6% to $5.08B, Advanced Technology solutions and Data‑Tech‑AI grew double digits, and adjusted diluted EPS increased ~11%, supporting the improved guidance. Genpact Reports Fourth Quarter and Full Year 2025 Results
- Neutral Sentiment: Analyst update mixed: Needham cut its price target from $53 to $50 but kept a “buy” rating, which is a modestly negative tweak but still supportive overall. The Fly – Price Target Lowered
- Neutral Sentiment: Technical/valuation commentary: Several outlets note the stock has been oversold and may be ripe for a rebound, which can attract contrarian/technical buyers but is not a fundamental catalyst by itself. Zacks – Ripe for a Turnaround
- Negative Sentiment: Conflicting/mixed EPS headlines: Some reports flagged a quarterly EPS miss (MarketBeat noted $0.82 vs. consensus $0.93), creating short-term uncertainty and headline volatility even as other outlets summarized beats—investors are parsing the reconciliation between reported GAAP figures, adjusted numbers, and how they tie into the stronger guidance. MarketBeat – Q4 Earnings Details
Hedge Funds Weigh In On Genpact
A number of large investors have recently made changes to their positions in G. AQR Capital Management LLC boosted its holdings in Genpact by 170.4% in the third quarter. AQR Capital Management LLC now owns 3,443,472 shares of the business services provider’s stock valued at $144,247,000 after purchasing an additional 2,170,145 shares during the last quarter. Ameriprise Financial Inc. lifted its holdings in shares of Genpact by 34.1% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,166,489 shares of the business services provider’s stock valued at $95,347,000 after buying an additional 551,269 shares during the period. Invesco Ltd. boosted its stake in shares of Genpact by 52.9% in the third quarter. Invesco Ltd. now owns 2,145,762 shares of the business services provider’s stock worth $89,886,000 after buying an additional 742,470 shares during the last quarter. UBS Group AG boosted its stake in shares of Genpact by 140.5% in the third quarter. UBS Group AG now owns 1,007,358 shares of the business services provider’s stock worth $42,198,000 after buying an additional 588,449 shares during the last quarter. Finally, Balyasny Asset Management L.P. grew its holdings in Genpact by 7.6% during the second quarter. Balyasny Asset Management L.P. now owns 892,778 shares of the business services provider’s stock worth $39,291,000 after acquiring an additional 63,156 shares during the period. 96.03% of the stock is owned by institutional investors and hedge funds.
Genpact Company Profile
Genpact is a global professional services firm specializing in digitally powered business process management and services. The company partners with clients across industries to design, transform and run key operations, leveraging data analytics, artificial intelligence, automation and domain expertise. Its offerings span finance and accounting, supply chain management, procurement, customer experience, risk and compliance, and other critical business functions.
Founded in 1997 as the business process outsourcing arm of General Electric and originally known as GE Capital International Services, the company rebranded as Genpact in 2005 and completed its initial public offering on the New York Stock Exchange in 2007 under the ticker symbol “G.” Over time, Genpact has expanded beyond traditional outsourcing to focus on digital transformation and innovation, helping organizations accelerate growth and improve operational efficiency.
Headquartered in New York City, Genpact serves clients in more than 30 countries across North America, Latin America, Europe and Asia Pacific.
Featured Stories
- Five stocks we like better than Genpact
- Trade this between 9:30 and 10:45 am EST
- New gold price target
- When to buy gold (mathematically)
- I’m 70 With $1.5M: Would Converting $120K a Year to a Roth Be Smart or a Costly Mistake? (Ask An Advisor)
- Wall Street’s New Sports Prediction Trade
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.
